46 completed, 5 unknown, 2 recruiting. 22 Not applicable, 13 Phase 1, 12 Phase 2, 4 Phase 3, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 22 | Completed 18, Unknown 3, Recruiting 1 |
| Phase 1 | 13 | Completed 11, Unknown 2 |
| Phase 2 | 12 | Completed 11, Unknown 1 |
| Phase 3 | 4 | Completed 4 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Population Council: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA Pro-type IVR - Contraceptive Usage | Early Phase 1 | Recruiting | Population Council | 60 | 2025-08-08 | 2025-09-05 |
| AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) ARROW strategies, One-time education - Cervical Cancer, Kaposi Sarcoma | Not applicable | Recruiting | Implenomics | 4100 | 2024-05-01 | 2026-11-04 |
| Forging Hopeful Futures to Reduce Youth Violence Forging Hopeful Futures, Wellness Check-ins - Violence in Adolescence, Racism | Not applicable | Completed | University of Pittsburgh | 542 | 2023-07-10 | 2026-09-03 |
| A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention Dual Prevention Pill, PrEP and combined oral contraceptive (COC) as two separate tablets - HIV Infections, Contraception | Not applicable | Completed | Population Council | 30 | 2022-12-07 | 2024-02-06 |
| Pilot Study on Engaging Family Physicians in Family Planning in Pakistan FP Training and Technical Support - Contraceptive Usage, Contraception | Not applicable | Unknown | Population Council | 76 | 2022-11-21 | 2022-12-13 |
| A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention Dual Prevention Pill, PrEP tablet and a COC as two separate tablets - HIV Infections | Not applicable | Unknown | Population Council | 96 | 2022-09-13 | 2024-02-06 |
| A Crossover Study Evaluating 3 Non-medicated Silicone IVRs Impact of ring size on adherence - Hiv, Pregnancy Related | Not applicable | Completed | Population Council | 48 | 2022-01-20 | 2023-02-09 |
| Integrated Care Delivery of HIV Prevention and Treatment in AGYW in Zambia SHIELD intervention (Support for HIV Integrated Education, Linkages to care, and Destigmatization), Integrated wellness care (IWC) clinics - HIV | Not applicable | Completed | RTI International | 2150 | 2021-05-10 | 2025-09-15 |
| A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg Levonorgestrel 1.5mg - Pregnancy Related | Completed | Camber Collective | 1980 | 2019-10-01 | 2021-11-05 | |
| Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception Nestorone + Testosterone Combination Gel - Healthy, Men | Phase 2 | Completed | Premier Research | 420 | 2018-10-25 | 2025-02-18 |
| Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision (EIMC) in Sub-Saharan Africa ShangRing, Mogen clamp - Circumcision | Not applicable | Completed | Weill Medical College of Cornell University | 1380 | 2018-10-01 | 2021-03-04 |
| Enhancing Male Participation in Interventions to Prevent Unintended Pregnancy The CHARM2 Intervention - Contraception | Not applicable | Completed | University of California, San Diego | 2402 | 2018-06-07 | 2022-09-06 |
| Addressing Reproductive Coercion in HEalth Settings - Kenya ARCHES Kenya - Unintended Pregnancy, Family Planning | Not applicable | Completed | University of California, San Diego | 659 | 2018-06-01 | 2023-02-13 |
| Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring NES-E2 CVR - Healthy Women, Female Contraception | Phase 2 | Completed | Premier Research | 385 | 2018-02-12 | 2025-10-31 |
| Project YES! Youth Engaging for Success Project YES! Youth Engaging for Success - HIV/AIDS | Not applicable | Completed | Johns Hopkins Bloomberg School of Public Health | 276 | 2017-12-15 | 2019-10-07 |
| Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women Griffithsin Gel, Placebo Gel - HIV Infection | Phase 1 | Completed | Population Council | 15 | 2017-10-01 | 2018-11-27 |
| Girl Empower: Studying the Impact of Mentorship, Asset Building, Caregiver Discussion Groups, and Cash Transfers on Reducing Girl's Vulnerability to Sexual Exploitation and Abuse Girl Empower Program - Adolescent Behavior, Sexual Violence | Not applicable | Unknown | Population Council | 2200 | 2017-07-12 | 2018-11-29 |
| Universal Coverage of Antiretroviral Treatment in Senegal Case management - HIV/AIDS | Not applicable | Completed | Johns Hopkins Bloomberg School of Public Health | 596 | 2017-06-05 | 2022-10-07 |
| A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA) Ulipristal Acetate IUS delivering Cu and 5μg, Ulipristal Acetate IUS delivering Cu and 20μg, Ulipristal Acetate IUS delivering Cu and 40μg - Contraception | Phase 1 | Unknown | Population Council | 30 | 2017-05-01 | 2017-08-15 |
| Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males Nestorone + Testosterone Combination Gel - Healthy Men, Male Contraception | Phase 1 | Completed | Kimberly Myer | 26 | 2017-01-01 | 2026-02-09 |
Showing 20 of 53. Sign in to see all of them.
HIV Infections (9) · Acquired Immunodeficiency Syndrome (6) · Sexually Transmitted Diseases (4) · Coitus (3) · Syphilis (3) · Trichomonas Vaginitis (3) · Adolescent Behavior (2) · Contraception Behavior (2) · HIV Seropositivity (2) · Alcohol Drinking (1) · Communication (1) · Herpes Simplex (1) · Lymphoma, Non-Hodgkin (1) · Maternal Death (1) · Multiple Endocrine Neoplasia Type 1 (1)
ST 1435 (7) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2) · Ethinyl Estradiol (2) · Levonorgestrel (2) · Palliative Care (2) · Ambulatory Care Facilities (1) · Behavior Therapy (1) · Case Management (1) · Contraceptives, Oral, Combined (1) · Gels (1) · Methods (1) · Moxifloxacin (1) · Organization and Administration (1) · Testosterone (1) · segesterone acetate and ethinyl estradiol vaginal system (1)
United States (21) · Dominican Republic (6) · Chile (5) · India (4) · South Africa (4) · Zambia (4) · Kenya (3) · Thailand (3) · Zimbabwe (3) · Pakistan (2) · Sweden (2) · Tanzania (2) · Australia (1) · Brazil (1) · Eswatini (1)
Barbara Friedland, MPH (4) · Anita Raj, PhD (3) · Christina Wang, MD (2) · Niranjan Saggurti, PhD (2) · Regine Sitruk-Ware, MD (2) · Ruth Merkatz, Ph.D. (2) · Alison Culyba, MD PhD MPH (1) · Appolinaire Tiam, MD (1) · Avina Sarna, MD (1) · Ayaz Ahmed Baloch (1) · Bradley Anawalt, MD (1) · Bruce Bvulani, MBChB, MMed (1) · Catherine McClean (1) · Charlotte E. Ellertson, MPA, Ph.D. (1) · Craig Hoesley, MD (1)
PMID 26267119, PMID 31231065, PMID 31398307, PMID 38295968, PMID 38479746, PMID 18193495, PMID 19059048, PMID 20098295, PMID 21915249, PMID 23148456, PMID 24607560, PMID 24795094, PMID 24993487, PMID 25976760, PMID 26032952, PMID 26381120, PMID 26438349, PMID 26563220, PMID 26830816, PMID 26897656, PMID 27167981, PMID 28679389, PMID 28873452, PMID 28930059, PMID 28993911, PMID 29097225, PMID 29269252, PMID 29315327, PMID 29500162, PMID 30180845, PMID 30245866, PMID 30349875, PMID 30556332, PMID 31584004, PMID 32026250, PMID 32240186, PMID 32266327, PMID 32322807, PMID 32460786, PMID 32608505, PMID 32793878, PMID 32813276, PMID 33251157, PMID 33428559, PMID 34014429, PMID 34193214, PMID 35051209, PMID 35274093, PMID 36113534, PMID 36328094
1UG3HD096908-01 (1), R01AI045468 (1), R01CE003502 (1)